fluorobenzenes has been researched along with Cardiomyopathies, Primary in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beanlands, RSB; deKemp, RA; Garrard, L; Hadizad, T; Mielniczuk, LM; Orlandi, C; Robinson, S; Walter, O; Zelt, JGE | 1 |
Li, WH; Ma, YX; Xie, Q | 1 |
De Amicis, V; Di Lello, F; Iorio, D; Mannacio, VA; Musumeci, F | 1 |
Bhandari, U; Javed, S; Kumar, V; Pathan, RA; Sharma, H | 1 |
Blake, K; Franz, MR; Laddu, A; Liem, LB; Peterson, J; Swerdlow, C | 1 |
1 trial(s) available for fluorobenzenes and Cardiomyopathies, Primary
Article | Year |
---|---|
Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a randomized trial.
Topics: Aged; Biomarkers; Cardiomyopathies; Cardiopulmonary Bypass; Coronary Artery Bypass; Double-Blind Method; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardium; Preoperative Care; Pyrimidines; Rosuvastatin Calcium; Sulfonamides | 2008 |
4 other study(ies) available for fluorobenzenes and Cardiomyopathies, Primary
Article | Year |
---|---|
PET imaging of sympathetic innervation with [
Topics: Aged; Cardiomyopathies; Ephedrine; Fluorobenzenes; Guanidines; Humans; Male; Myocardial Ischemia; Positron Emission Tomography Computed Tomography; Risk; ST Elevation Myocardial Infarction; Sympathetic Nervous System | 2019 |
Rosuvastatin inhibits TGF-beta1 expression and alleviates myocardial fibrosis in diabetic rats.
Topics: Animals; Body Weight; Cardiomyopathies; Collagen; Creatine Kinase; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Fibrosis; Fluorobenzenes; Glycated Hemoglobin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertrophy, Left Ventricular; Male; Natriuretic Peptide, Brain; Pyrimidines; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Rosuvastatin Calcium; Sulfonamides; Transforming Growth Factor beta1 | 2013 |
Anti-apoptotic potential of rosuvastatin pretreatment in murine model of cardiomyopathy.
Topics: Animals; Apoptosis; Cardiomyopathies; Cardiotonic Agents; Disease Models, Animal; Doxorubicin; Fluorobenzenes; Male; Pyrimidines; Rats; Rats, Wistar; Rosuvastatin Calcium; Sulfonamides | 2011 |
Electropharmacology of flestolol for supraventricular tachycardia without associated structural heart disease.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Cardiac Pacing, Artificial; Cardiomyopathies; Electrocardiography; Electrophysiology; Female; Fluorobenzenes; Humans; Male; Middle Aged; Propanolamines; Tachycardia, Supraventricular | 1987 |